SCHEMBL32663566

SCHEMBL32663566

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5COCCO5)c([N+](=O)[O-])c4)c(Oc4ccc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 4/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1956218 1.00 BCL2 (1.00) BCL2
SCHEMBL1957161 1.00 BCL2 (1.00) BCL2
SCHEMBL1702067 1.00 BCL2 (1.00) BCL2
SCHEMBL19424849 0.94 BCL2 (0.88) BCL2
SCHEMBL19424945 0.94 BCL2 (0.88) BCL2
SCHEMBL1959178 0.94 BCL2 (1.00) BCL2
SCHEMBL1701434 0.93 BCL2 (0.87) BCL2
SCHEMBL1699781 0.93 BCL2 (0.87) BCL2
SCHEMBL29796282 0.93 BCL2 (0.87) BCL2
SCHEMBL30314021 0.93 BCL2 (0.87) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4682148-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES AbbVie Ireland Unlimited Company (IE) 2026-01-21 — — EP disclosed
Send feedback